Analysis of transcriptome data from The Cancer Genome Atlas-Prostate Adenocarcinoma (TCGA-PRAD) cohort (n = 499; ref. 34) revealed that MALAT1 expression positively correlates with several clinicopathologic parameters such as Gleason score and node status (Supplementary Fig. S1A). The gene discussed is MALAT1; the disease is prostate adenocarcinoma.